{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:37Z","timestamp":1787760637993,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-026-00813-z","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:25:18Z","timestamp":1770819918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pretreatment immunoglobulin profiles and survival outcomes in hematologic malignancies and autoimmune cytopenias: a comparative cohort analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Mehmet Emin","family":"Gerek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atakan","family":"Tekinalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"\u00c7\u00f6lkesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba","family":"\u00d6nalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Arzu","family":"Akku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eevket","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"8","key":"813_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804\u201315.","journal-title":"N Engl J Med"},{"issue":"9","key":"813_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.24826","volume":"92","author":"M Hallek","year":"2017","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2017;92(9):946\u201365.","journal-title":"Am J Hematol"},{"issue":"7","key":"813_CR3","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3109\/10428194.2016.1142082","volume":"57","author":"MA Andersen","year":"2016","unstructured":"Andersen MA, Vojdeman FJ, Andersen MK, Brown P, Geisler CH, Weis Bjerrum O, et al. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death. Leuk Lymphoma. 2016;57(7):1592\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"813_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the united States, 1992\u20132001. Blood. 2006;107(1):265\u201376.","journal-title":"Blood"},{"issue":"22","key":"813_CR5","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1158\/0008-5472.CAN-07-1751","volume":"67","author":"KE Smedby","year":"2007","unstructured":"Smedby KE, Hjalgrim H, Chang ET, Rostgaard K, Glimelius B, Adami HO, et al. Childhood social environment and risk of non-Hodgkin lymphoma in adults. Cancer Res. 2007;67(22):11074\u201382.","journal-title":"Cancer Res"},{"issue":"11","key":"813_CR6","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386\u201393.","journal-title":"Blood"},{"issue":"1","key":"813_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","volume":"25","author":"J Wang","year":"2005","unstructured":"Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25(1):57\u201362.","journal-title":"J Autoimmun"},{"issue":"2","key":"813_CR8","first-page":"79","volume":"9","author":"N Colovic","year":"2001","unstructured":"Colovic N, Bogdanovic A, Martinevic-Cemerkic V, Jankovic G. Prognostic significance of serum immunoglobulins in B-chronic lymphocytic leukemia. Arch Oncol. 2001;9(2):79\u201382.","journal-title":"Arch Oncol"},{"issue":"14","key":"813_CR9","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1182\/bloodadvances.2018026591","volume":"3","author":"G Ishdorj","year":"2019","unstructured":"Ishdorj G, Streu E, Lambert P, Dhaliwal HS, Mahmud SM, Gibson SB, et al. IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia. Blood Adv. 2019;3(14):2188\u201398.","journal-title":"Blood Adv"},{"issue":"6","key":"813_CR10","first-page":"374","volume":"78","author":"S Molica","year":"1993","unstructured":"Molica S, Levato D, Levato L. Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up. Haematologica. 1993;78(6):374\u20137.","journal-title":"Haematologica"},{"issue":"1","key":"813_CR11","first-page":"33","volume":"3","author":"F Kus","year":"2023","unstructured":"Kus F, Bektas M, Senkal N, Catma Y, Atalah F, Akyildiz A, et al. Prognostic and predictive value of baseline hypogammaglobulinemia for chronic lymphocytic leukemia prognosis and complications. Eurasian J Med Adv. 2023;3(1):33\u20139.","journal-title":"Eurasian J Med Adv"},{"key":"813_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00626","volume":"5","author":"N Compagno","year":"2014","unstructured":"Compagno N, Malipiero G, Cinetto F, Agostini C. Immunoglobulin replacement therapy in secondary hypogammaglobulinemia. Front Immunol. 2014;5:626.","journal-title":"Front Immunol"},{"issue":"3","key":"813_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4274\/haseki.85057","volume":"56","author":"M Ayer","year":"2018","unstructured":"Ayer M, Akay \u00c7M, Ayer FA, \u00d6zmen D, Elibol T. Evaluation of hypogammaglobulinemia in chronic lymphocytic leukemia patients and its relation to poor prognostic factors. Med Bull Haseki. 2018;56(3):181\u20136.","journal-title":"Med Bull Haseki"},{"issue":"2","key":"813_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4","volume":"61","author":"C Rozman","year":"1988","unstructured":"Rozman C, Montserrat E, Vi\u00f1olas N. Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance. Cancer. 1988;61(2):279\u201383.","journal-title":"Cancer"},{"issue":"S1","key":"813_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/01.HS9.0000566140.61924.d5","volume":"3","author":"E Umit","year":"2019","unstructured":"Umit E, Baysal M, Bas V, Gulsaran S, Demirci U, Kirkizlar O, et al. Hypogammaglobulinemia as a predictor of survival in older patients with chronic lymphocytic leukemia. HemaSphere. 2019;3(S1):870. https:\/\/doi.org\/10.1097\/01.HS9.0000566140.61924.d5.","journal-title":"HemaSphere"},{"issue":"11","key":"813_CR16","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1002\/ijc.24245","volume":"124","author":"RJ Biggar","year":"2009","unstructured":"Biggar RJ, Christiansen M, Rostgaard K, Smedby KE, Adami HO, Glimelius B, et al. Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer. 2009;124(11):2616\u201320.","journal-title":"Int J Cancer"},{"issue":"1","key":"813_CR17","doi-asserted-by":"publisher","first-page":"e2021018","DOI":"10.4084\/mjhid.2021.018","volume":"13","author":"S Ramadan","year":"2021","unstructured":"Ramadan S, Ceparano G, Cignetti A, Sammassimo S, Bagnardi V, Pagan E, et al. Prognostic impact of baseline immunologic profile in aggressive B-cell non-Hodgkin\u2019s lymphomas. Mediterr J Hematol Infect Dis. 2021;13(1):e2021018.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"813_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1334899","volume":"15","author":"D Brazel","year":"2024","unstructured":"Brazel D, Grant C, Cabal A, Chen WP, Pinter-Brown L. Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis. Front Immunol. 2024;15:1334899.","journal-title":"Front Immunol"},{"issue":"4","key":"813_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040826","volume":"16","author":"A Duminuco","year":"2024","unstructured":"Duminuco A, Santuccio G, Chiarenza A, Figuera A, Motta G, Caruso AL, et al. Baseline IgM amounts can identify patients with poor outcomes: results from a real-life single-center study on classical Hodgkin lymphoma. Cancers (Basel). 2024;16(4):826. https:\/\/doi.org\/10.3390\/cancers16040826.","journal-title":"Cancers (Basel)"},{"key":"813_CR20","doi-asserted-by":"publisher","DOI":"10.21911\/aai.500","author":"G Aytekin","year":"2019","unstructured":"Aytekin G, Y\u0131ld\u0131z E, \u00c7\u00f6lkesen F, Y\u0131lmaz S, Tekinalp A, Demircio\u011flu S, et al. Reverse angle: immunological evaluation of patients with idiopathic thrombocytopenic purpura: a retrospective cohort study. Asthma Allergy Immunol. 2019. https:\/\/doi.org\/10.21911\/aai.500.","journal-title":"Asthma Allergy Immunol"},{"issue":"1","key":"813_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.21608\/ejhm.2021.165493","volume":"83","author":"RA Radwan","year":"2021","unstructured":"Radwan RA, Soliman ARA, Adel A, Mohamed HS. Immunoglobulin A and immunoglobulin M and their relation to treatment response in adult Egyptian immune thrombocytopenic purpura patients. Egypt J Hosp Med. 2021;83(1):1284\u20139.","journal-title":"Egypt J Hosp Med"},{"issue":"17","key":"813_CR22","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1002\/cncr.29438","volume":"121","author":"SA Parikh","year":"2015","unstructured":"Parikh SA, Leis JF, Chaffee KG, Call TG, Hanson CA, Ding W, et al. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: natural history, clinical correlates, and outcomes. Cancer. 2015;121(17):2883\u201391.","journal-title":"Cancer"},{"issue":"1","key":"813_CR23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194925","volume":"144","author":"Y Yao","year":"2024","unstructured":"Yao Y, Rabe KG, Allmer C, Kleinstern G, Boddicker NJ, Tian S, et al. Serum immunoglobulins are an independent prognostic marker of time to first therapy in newly diagnosed chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL). Blood. 2024;144(1):4616. https:\/\/doi.org\/10.1182\/blood-2024-194925.","journal-title":"Blood"},{"issue":"3","key":"813_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4103\/joah.joah_205_20","volume":"12","author":"FA Fasola","year":"2021","unstructured":"Fasola FA, Olaniyi JA, Kotila TR, Ogundeji SP. Serum immunoglobulin subclass levels in non-Hodgkin\u2019s lymphoma in Ibadan, South Western Nigeria. J Appl Hematol. 2021;12(3):158\u201362.","journal-title":"J Appl Hematol"},{"issue":"1","key":"813_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/mco.2014.421","volume":"3","author":"A Ko\u0142tan","year":"2015","unstructured":"Ko\u0142tan A, Ko\u0142tan S, D\u0119bski R, Grze\u015bk E, Wysocki M, Grze\u015bk G. An assessment of selected immune parameters of patients with Hodgkin\u2019s disease. Mol Clin Oncol. 2015;3(1):237\u201343.","journal-title":"Mol Clin Oncol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-026-00813-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-026-00813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:09:09Z","timestamp":1773752949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12865-026-00813-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1186\/s12865-026-00813-z","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Necmettin Erbakan University, Faculty of Medicine (Approval No: 2025\/5861). All procedures were conducted in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was waived due to the retrospective design of the study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}